Literature DB >> 12029638

Defective regulation of cholangiocyte Cl-/HCO3(-) and Na+/H+ exchanger activities in primary biliary cirrhosis.

Saida Melero1, Carlo Spirlì, Akos Zsembery, Juan F Medina, Ruth E Joplin, Elena Duner, Massimo Zuin, James M Neuberger, Jesús Prieto, Mario Strazzabosco.   

Abstract

Primary biliary cirrhosis (PBC) is a disorder of unknown origin with autoimmune features. Recently, impaired biliary secretion of bicarbonate has been shown in patients with PBC. Here we have investigated whether bile duct epithelial cells isolated from PBC patients exhibit defects in transepithelial bicarbonate transport by analyzing the activities of 2 ion exchangers, Cl(-)/HCO3(-) anion exchanger 2 (AE2) and Na(+)/H(+) exchanger (NHE) in isolated cholangiocytes. AE2 and NHE activities were studied in basal conditions and after stimulation with cyclic adenosine monophosphate (cAMP) and extracellular adenosine triphosphate (ATP), respectively. Cholangiocytes were grown from needle liver biopsies from 12 PBC patients, 8 normal controls, and 9 patients with other liver diseases. Also, intrahepatic cholangiocytes were cultured after immunomagnetic isolation from normal liver tissue (n = 6), and from recipients undergoing liver transplantation for end-stage PBC (n = 9) and other forms of liver disease (n = 8). In needle-biopsy cholangiocytes, basal AE2 activity was significantly decreased in PBC as compared with normal livers and disease controls. In addition, we observed that though cAMP increased AE2 activity in cholangiocytes from both normal and non-PBC livers, this effect was absent in PBC cholangiocytes. Similarly, though in cholangiocytes from normal and disease control livers extracellular ATP induced a marked enhancement of NHE activity, cholangiocytes from PBC patients failed to respond to purinergic stimulation. In conclusion, our findings provide functional evidence that PBC cholangiocytes exhibit a widespread failure in the regulation of carriers involved in transepithelial H(+)/HCO3(-) transport, thus, providing a molecular basis for the impaired bicarbonate secretion in this cholestatic syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029638     DOI: 10.1053/jhep.2002.33634

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 2.  MicroRNAs and benign biliary tract diseases.

Authors:  Sergio A Gradilone; Steven P O'Hara; Tetyana V Masyuk; Maria Jose Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  MicroRNAs in biliary diseases.

Authors:  Patricia Munoz-Garrido; Maite García-Fernández de Barrena; Elizabeth Hijona; Miguel Carracedo; José J G Marín; Luis Bujanda; Jesús M Banales
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

4.  Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Authors:  Jesús M Banales; Elena Sáez; Miriam Uriz; Sarai Sarvide; Aura D Urribarri; Patrick Splinter; Pamela S Tietz Bogert; Luis Bujanda; Jesús Prieto; Juan F Medina; Nicholas F LaRusso
Journal:  Hepatology       Date:  2012-07-10       Impact factor: 17.425

5.  MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation.

Authors:  Oihane Erice; Patricia Munoz-Garrido; Javier Vaquero; Maria J Perugorria; Maite G Fernandez-Barrena; Elena Saez; Alvaro Santos-Laso; Ander Arbelaiz; Raul Jimenez-Agüero; Joaquin Fernandez-Irigoyen; Enrique Santamaria; Verónica Torrano; Arkaitz Carracedo; Meenakshisundaram Ananthanarayanan; Marco Marzioni; Jesus Prieto; Ulrich Beuers; Ronald P Oude Elferink; Nicholas F LaRusso; Luis Bujanda; Jose J G Marin; Jesus M Banales
Journal:  Hepatology       Date:  2018-02-21       Impact factor: 17.425

Review 6.  Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.

Authors:  Michael Trauner; Peter Fickert; Emina Halilbasic; Tarek Moustafa
Journal:  Wien Med Wochenschr       Date:  2008

7.  Differentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation.

Authors:  Mario Strazzabosco; Romina Fiorotto; Saida Melero; Shannon Glaser; Heather Francis; Carlo Spirli; Gianfranco Alpini
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

8.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01

9.  Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis.

Authors:  Brian D Juran; Elizabeth J Atkinson; Joseph J Larson; Erik M Schlicht; Konstantinos N Lazaridis
Journal:  Am J Gastroenterol       Date:  2009-04-21       Impact factor: 10.864

Review 10.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.